18 Share Tips – 16 January 2023
John Athanasiou, Red Leaf Securities BUY RECOMMENDATIONS Spenda (SPX) Spenda supplies industries with a broad range of business-to-business payment services. In December 2022, the company announced its platform would be rolled out to the Carpet Court franchise network. It also announced it had entered into a new two-year payment facilitator agreement with Fiserv. We expect…
18 Share Tips – 19 December 2022
Tony Langford, Seneca BUY RECOMMENDATIONS Dexus (DXS) This fully integrated real estate group manages an Australian property portfolio valued at $44.3 billion. The industrial and office portfolios retain high occupancy and rent collection rates above 95 per cent. During the September quarter, it transacted about $900 million across the group, predominantly divestments. It was recently…
18 Share Tips – 12 December 2022
Tony Locantro, Alto Capital BUY RECOMMENDATIONS Nyrada Inc. (NYR) NYR is a pre-clinical stage drug development company. It has announced the design protocol for the phase 1 trial of the PCSK9 cholesterol inhibitor set for the clinic in fiscal year 2023. The trial will involve healthy volunteers and others with high cholesterol. Further toxicology studies…
18 Share Tips – 5 December 2022
Elio D’Amato, Spotee Connect BUY RECOMMENDATIONS Technology One (TNE) Supported by its loyal and expanding client base, this cloud-based software solutions provider delivered an excellent full year report. While some may be quick to point to its lofty valuation, TNE remains one of the highest quality companies on the ASX, in our opinion. It offers…
18 Share Tips – 28 November 2022
John Athanasiou, Red Leaf Securities BUY RECOMMENDATIONS Appen (APX) The share price of this artificial intelligence data provider has fallen from $40.08 on August 17, 2020 to trade at $2.65 on November 24, 2022. The company expects fiscal year 2022 revenue to range between $US375 million and $US395 million. We expect the share price to…
18 Share Tips – 21 November 2022
Braden Gardiner, Tradethestructure BUY RECOMMENDATIONS Capitol Health (CAJ) CAJ provides diagnostic imaging and related services to the healthcare market. Revenue of $184.2 million in fiscal year 2022 was up 3.5 per cent on the prior corresponding period. Operating EBITDA of $41.1 million was down 2.6 per cent, but we’re expecting it to climb in response to…
18 Share Tips – 14 November 2022
Tim Haselum, Catapult Wealth BUY RECOMMENDATIONS Goodman Group (GMG) Goodman is an industrial property group. Recently rising bond yields and exposure to Europe are short-term concerns. However, over the longer term, we believe GMG now presents a good buying opportunity given near full occupancy and a development pipeline of about $13 billion. In our view,…
18 Share Tips – 7 November 2022
Chris Batchelor, Spotee Connect BUY RECOMMENDATIONS Grange Resources (GRR) The producer sells iron ore pellets from its Savage River mine in Tasmania. The iron ore price has been declining recently following concerns of slowing activity in China. We believe the Grange share price fall has been excessive given the higher quality ore it produces. Therefore,…
18 Share Tips – 31 October 2022
Stuart Bromley, Medallion Financial Group BUY RECOMMENDATIONS PolyNovo (PNV) The company provides dermal regeneration solutions via its NovoSorb biodegradable polymer technology. The company posted unaudited record first quarter sales of $12.5 million in fiscal year 2023. We’re encouraged that Swami Raote, a former US Johnson & Johnson veteran of 30 years, was appointed chief executive…
18 Share Tips – 24 October 2022
Jabin Hallihan, Morgans BUY RECOMMENDATIONS Treasury Wine Estates (TWE) This global wine company has more than 70 brands in its portfolio, including the iconic Penfolds brand. We believe the company is trading at a discount. Our 12-month price target is $15.71. The shares closed at $12.83 on October 20. According to our forecasts, we expect…
